Variant report
Variant | esv1800457 |
---|---|
Chromosome Location | chr9:10626531-10644894 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:13)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:13 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr9:10635667-10636010 | A549 | lung: | n/a | chr9:10635839-10635852 chr9:10635840-10635851 chr9:10635841-10635850 |
2 | CEBPB | chr9:10631704-10631897 | H1-hESC | embryonic stem cell: | n/a | n/a |
3 | CEBPB | chr9:10635685-10636024 | IMR90 | lung: | n/a | chr9:10635839-10635852 chr9:10635840-10635851 chr9:10635841-10635850 |
4 | CEBPB | chr9:10635667-10636017 | HepG2 | liver: | n/a | chr9:10635839-10635852 chr9:10635840-10635851 chr9:10635841-10635850 |
5 | EP300 | chr9:10626972-10626974 | GM12878 | blood: | n/a | n/a |
6 | FAM48A | chr9:10637606-10637717 | GM12878 | blood: | n/a | n/a |
7 | POLR2A | chr9:10644861-10645120 | MCF10A-Er-Src | breast: | n/a | n/a |
8 | POLR2A | chr9:10644152-10644352 | MCF10A-Er-Src | breast: | n/a | n/a |
9 | POLR2A | chr9:10637051-10637129 | MCF10A-Er-Src | breast: | n/a | n/a |
10 | POLR2A | chr9:10631606-10631747 | MCF10A-Er-Src | breast: | n/a | n/a |
11 | STAT3 | chr9:10633856-10634056 | MCF10A-Er-Src | breast: | n/a | n/a |
12 | STAT3 | chr9:10642453-10642635 | MCF10A-Er-Src | breast: | n/a | n/a |
13 | STAT3 | chr9:10631990-10632518 | MCF10A-Er-Src | breast: | n/a | chr9:10632246-10632254 |
No data |
No data |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-PTPRD-1 | chr9:10632083-10632203 | ENSG00000232035 |
2 | lnc-PTPRD-1 | chr9:10631750-10631785 | ENSG00000232035 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000232035 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs542132771 | chr9:10631208-10631209 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs562436361 | chr9:10631213-10631214 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs527869243 | chr9:10631217-10631218 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs78777076 | chr9:10631368-10631369 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs564346093 | chr9:10631409-10631410 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs550145426 | chr9:10631432-10631433 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs532040890 | chr9:10631490-10631491 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs551872816 | chr9:10631522-10631523 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs568731857 | chr9:10631545-10631546 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs566964110 | chr9:10631549-10631550 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs536136256 | chr9:10631553-10631554 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs371546578 | chr9:10631565-10631566 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs531366307 | chr9:10631578-10631579 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs1322295 | chr9:10631603-10631604 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs568385607 | chr9:10631609-10631610 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs566661573 | chr9:10631639-10631640 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs181839836 | chr9:10631653-10631654 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs553968754 | chr9:10631656-10631657 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs185034009 | chr9:10631745-10631746 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs539913267 | chr9:10631763-10631764 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
21 | rs72547155 | chr9:10631776-10631777 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
22 | rs553107384 | chr9:10631777-10631778 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
23 | rs397819617 | chr9:10631784-10631785 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
24 | rs370097982 | chr9:10631785-10631786 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
25 | rs372000369 | chr9:10631786-10631787 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs556720116 | chr9:10631789-10631790 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs143244813 | chr9:10632083-10632084 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
28 | rs71216125 | chr9:10632111-10632112 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
29 | rs75081343 | chr9:10632114-10632115 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
30 | rs375514977 | chr9:10632115-10632116 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
31 | rs71501072 | chr9:10632116-10632117 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
32 | rs10959208 | chr9:10632118-10632119 | Inactive region | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs557385962 | chr9:10632152-10632153 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
34 | rs181042100 | chr9:10632156-10632157 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
35 | rs1322298 | chr9:10632165-10632166 | Inactive region | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs561535382 | chr9:10632167-10632168 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
37 | rs1322299 | chr9:10632181-10632182 | Inactive region | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs547735675 | chr9:10632206-10632207 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs570637939 | chr9:10632231-10632232 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs539676680 | chr9:10632263-10632264 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs549995367 | chr9:10632276-10632277 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs372502014 | chr9:10632292-10632293 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs559957199 | chr9:10632294-10632295 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs570176852 | chr9:10632303-10632304 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs535579131 | chr9:10632311-10632312 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs555694244 | chr9:10632357-10632358 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs10959209 | chr9:10632384-10632385 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs10809141 | chr9:10632427-10632428 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs10809142 | chr9:10632430-10632431 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs73398297 | chr9:10632452-10632453 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
abnormal development | 18461090 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
XY gonadal dysgenesis | 20685758 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma | 19074898 | CNVD |
Malignant melanoma | 19074898 | CNVD |
Prostate cancer | 16573809 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Cancer | 20164920 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 21764851 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioma | 17123091 | CNVD |
Lung cancer | 16773561 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Gastric cancer | 16891809 | CNVD |
Mental retardation | 17847001 | CNVD |
Cutaneous squamous cell carcinomas | 17420988 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21611746 | CNVD |
Melanoma | 22183965 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Renal cell carcinoma | 21215367 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:10631200-10631800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
2 | chr9:10633200-10633600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr9:10640400-10640800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |